Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Welfide Corp
Original Assignee
Santen Pharmaceutical Co Ltd
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd, Welfide CorpfiledCriticalSanten Pharmaceutical Co Ltd
Priority to JP7540679ApriorityCriticalpatent/JPS5848556B2/en
Publication of JPS55167280ApublicationCriticalpatent/JPS55167280A/en
Publication of JPS5848556B2publicationCriticalpatent/JPS5848556B2/en
USE: A remedy for hypertension and rheumatism having an angiotensin-I converting enzyme inhibitory action and reduced dysgeusia, and usable for preventing and treating diseases caused by zinc deficiency.
PROCESS: A compound of formula II (M is alkali metal) is reacted with a zinc halide or hydroxide, zinc salt of a lower fatty acid or zinc carbonate or sulfate to give the compound of formula I.
COPYRIGHT: (C)1980,JPO&Japio
JP7540679A1979-06-141979-06-14
Zinc compounds and their production method
ExpiredJPS5848556B2
(en)